PRAX
Praxis Precision Medicines, Inc.
Latest Form 4:Sale$3.6MbyDeSimone Jill (Director) · filed Jun 26, 2026
Praxis Precision Medicines, Inc. (PRAX) has 36 SEC Form 4 filings (84 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.
Insiders have net sold $3.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Marcio Silva De'Souza
- Employees:168
- HQ:Boston, MA, US
- IPO:2020-10-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$44.3M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$10.3B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
DeSimone JillFirst filing | Director | Sale | 11,600 | $3.6M | Jun 26 | SEC ↗ |
Mastrocola LaurenFirst filing | Principal Accounting Officer | Sale | 13,600 | $2.6M | Nov 21 | SEC ↗ |
Nemiroff AlexFirst filing | General Counsel and Secretary | Sale | 25,130 | $4.9M | Nov 21 | SEC ↗ |
Adage Capital Management, L.P.First filing | 10% Owner | Sale | 313,910 | $33.2M | Oct 17 | SEC ↗ |
Related companies
Praxis Precision Medicines, Inc. is in the Healthcare sector.